Previous Article | Next Article ![]()
Infect Immun, April 1998, p. 1632-1637, Vol. 66, No. 4
Department of Microbiology and Immunology,
Stanford University, Stanford, California
94305-51241;
Department of Immunology,
Palo Alto Medical Foundation, Palo Alto, California
943012; and
Department of Molecular
Microbiology3 and
Department of
Genetics,4 Washington University, St. Louis,
Missouri 63110
Received 3 November 1997/Returned for modification 8 December
1997/Accepted 11 January 1998
Toxoplasma gondii is a protozoan parasite responsible
for widespread infections in humans and animals. Two major asexual
forms are produced during the life cycle of this parasite: the rapidly dividing tachyzoite and the more slowly dividing, encysted bradyzoite. To further study the differentiation between these two forms, we have
generated a large number of expressed sequence tags (ESTs) from both
asexual stages. Previously, we obtained data on ~7,400 ESTs from
tachyzoites (J. Ajioka et al., Genome Res. 8:18-28, 1998). Here, we
report the results from analysis of ~2,500 ESTs from bradyzoites
purified from the cysts of infected mice. We also report the results
from analysis of 760 ESTs from parasites induced to differentiate from
tachyzoites to bradyzoites in vitro. Comparison of the data sets from
bradyzoites and tachyzoites reveals many previously uncharacterized
sequence clusters which are largely or completely specific to one or
other developmental stage. This class includes a bradyzoite-specific
form of enolase. Combined with the previously identified
bradyzoite-specific form of lactate dehydrogenase, this finding
suggests significant differences in flux through the lower end of the
glycolytic pathway in this stage. Thus, the generation of this data set
provides valuable insights into the metabolism and growth of the
parasite in the encysted form and represents a substantial body of
information for further study of development in Toxoplasma.
Toxoplasma gondii is a
member of the protozoan phylum Apicomplexa, which also includes the
causative agents of malaria (Plasmodium spp.), coccidiosis
(Eimeria spp.), and cryptosporidiosis
(Cryptosporidium spp.). T. gondii is a major
pathogen of a broad range of warm-blooded animals, including humans,
livestock, and domestic pets (11). The parasite is of
clinical importance both for the devastating disease it causes in the
developing fetus and as an opportunistic infection in patients
immunocompromised through disease or transplantation (19).
The parasite has a complex life cycle that includes sexual and asexual
stages. The sexual cycle occurs exclusively in the guts of felines,
while asexual growth can occur in almost any tissue of its broad range
of hosts. The asexual cycle has two major forms: the rapidly dividing
tachyzoite and the more slowly dividing, encysted bradyzoite.
Tachyzoites are not normally responsible for host-to-host transmission
and instead serve to disseminate infection within a given animal by
invading and rapidly multiplying in a wide range of nucleated cells. In
apparent response to immune pressure from the host, T. gondii tachyzoites differentiate into bradyzoites, which grow
within cyst-like structures in the host tissue. When ingested,
bradyzoites are infectious both to cats (resulting in entry into the
sexual cycle) and other intermediate hosts, where further asexual
growth can occur. Spontaneous reactivation of the disease through
rupture of the cysts and dissemination of T. gondii
tachyzoites can result in fatal encephalitis in patients with AIDS.
Tachyzoites and bradyzoites differ in a number of surface antigens
(6) as well as important metabolic enzymes (10, 33, 34). Because of the difficulty of obtaining large amounts of tissue cysts from infected animals, however, it has been difficult to
characterize bradyzoites in detail. Tachyzoites can be induced to
differentiate in vitro through a variety of stresses (reviewed in
reference 4) into forms which resemble bradyzoites
by both morphological and antigenic criteria. Such in vitro bradyzoites have proved invaluable both in enabling the identification of bradyzoite-specific genes (16) and in providing initial
insights into the mechanisms that control gene expression in this stage (5). However, the extent to which in vitro bradyzoites
resemble parasites found in vivo is unclear.
To understand more about this important stage in the asexual cycle of
the parasite, we have generated a large number of bradyzoite expressed
sequence tags (ESTs) that complement the data already obtained from the
tachyzoite stage (1). We also report here the results of an
EST analysis from tachyzoites induced to switch to bradyzoites in vitro
following 6 days of growth at high pH (29). As with a
similar study of mammalian cells (17) in various states of
differentiation, this analysis reveals many genes that appear to be
developmentally regulated in addition to a large number of putative
housekeeping genes that are expressed constitutively.
Parasites.
The RNA preparation from differentiating parasites.
Human
foreskin fibroblasts cells were grown in Dulbecco's modified Eagle's
medium (DMEM) supplemented with 10% Nu-Serum and 2 mM glutamine and
cultured at 37°C in 5% CO2. Monolayers were infected
with ~105 tachyzoites of the PDS strain per
cm2. Four hours later, all remaining extracellular
parasites were removed by repeated rinsing of the monolayer with
prewarmed DMEM. The culture medium was replaced with RPMI 1640 medium,
pH 8.1, containing 5% fetal bovine serum, 50 mM HEPES, and 20 mg of
gentamicin per liter, and the cells were incubated in a humid air
atmosphere at 37°C. The pH of the culture medium equilibrated in the
range of 8.1 to 8.2 and was monitored daily. The parasites were allowed to differentiate and encyst under these conditions and were harvested on day 6 after infection. The medium was changed every two days during
this time.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Expressed Sequence Tag Analysis of the
Bradyzoite Stage of Toxoplasma gondii: Identification
of Developmentally Regulated Genes
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
gt11 in vivo cyst library (26)
was generated from T. gondii ME49, a prototypical type II
strain (28). RNA for the library from differentiating
parasites was isolated from a cloned derivative of the ME49 strain
designated PDS.
Library construction. (i) ME49 in vivo bradyzoite cDNA
library.
Construction of the ME49 in vivo bradyzoite cDNA library
in
gt11 is described in detail in reference 26.
Briefly, tissue cysts of ME49 parasites were isolated from the brains
of CBA/Ca mice 6 weeks after oral infection (14) and
digested briefly with pepsin-HCl to release bradyzoites. Total RNA was
isolated from approximately 8 × 107 bradyzoites by
the guanidine isothiocyanate method (7). Single-stranded cDNA was made from poly(A)+ RNA with an
NotI-oligo(dT) adapter primer
[5'-CAATTCGCGGGCCGC(T)15-3'], and its second strand was
synthesized with DNA polymerase I and RNase H. Flushed cDNA was ligated
to Universal PCR adapters (Clontech) containing internal
EcoRI sites. PCR amplification was carried out for 35 cycles, and products were digested with EcoRI and
NotI. Fragments were ligated directionally into the
corresponding sites of the
gt11 Sfi-Not vector.
(Stratagene) and transformed into E. coli
DH10. The size distribution of the inserts was determined by PCR
amplification in 20 individual clones with the T3 and T7 primers. This
subcloned library was plated to a density of about 200 colonies per
plate, and 4,224 individual colonies were picked by hand and
transferred to 11 384-well dishes containing Luria-Bertani medium-100
µg of ampicillin per ml-8% glycerol. Inoculated dishes were sealed
and incubated for 14 h at 37°C. Locations of wells without
growth were recorded, and the original plates were frozen at
80°C
for shipping following replication into fresh plates with a 384-pin
block.
(ii) ME49 in vitro bradyzoite library.
cDNA was synthesized
from poly(A)+ RNA by using the cDNA Synthesis Kit
(Stratagene) according to the manufacturer's instructions. After
second-strand synthesis and ligation of EcoRI adapters, double-stranded cDNA was digested with XhoI and ligated into
UniZAP XR. Individual clones for sequencing were selected from the
primary library obtained after packaging.
Cycle sequencing, processing, and database submission. (i) ME49 in vivo bradyzoite cDNA library. Individual clones were transferred to 96-well plates containing Luria-Bertani medium and grown overnight. Identification numbers consisting of TgESTzz followed by a plate number, row letter, and column number were assigned to each clone. Bacteria from each well were diluted in water, and PCR amplification of insert fragments was performed with T3 and T7 primers in MJ Research PTC 200 thermal cyclers. Amplification products were diluted in water and used as templates for 5' sequencing with DYEnamic ET T7 dye primers.
Cycle sequencing, gel image analysis, and DNA sequence extraction were performed as described previously (1). Processed sequence data were annotated with similarity information, sequence quality information, and library information and then submitted to dBEST/GenBank. dBEST entries for this project are clearly annotated to indicate the library source from which ESTs were derived. Data from a pilot scale study (153 ESTs) of the bradyzoite library prior to size selection (GenBank accession no. AA274250 through AA274402) was also submitted but was not included in the analysis described here. ESTs derived from the in vivo library after size selection are designated "size-selected" in the library title field to indicate this fact. A small number of human and mouse cDNAs derived from the host cells from which Toxoplasma was isolated were revealed by sequencing of these libraries. dBEST entries have been annotated to indicate such contaminants. A note warning of the possibility that ESTs from these libraries may correspond to previously unidentified host sequences has also been included with the dBEST entries for these clones. Furthermore, since the in vivo bradyzoite library was obtained by PCR amplification, it is possible that genomic contaminants may also be represented.(ii) ME49 in vitro bradyzoite library. Analysis of this library was performed as previously described (1).
Cluster analysis and comparison to the tachyzoite EST database. The in vivo bradyzoite size-selected EST data set (2,353 ESTs) was downloaded from dBEST and processed with READSEQ using BCM Search Launcher. The data file in FASTA format was assembled into 610 contigs containing pointers to 2,258 ESTs with TIGR_Assembler and N2TOOL (from the ICAASS suite, J. Parsons, European Bioinformatics Institute) after exclusion of 17 sequences less than 60 nucleotides long. Contigs were then reBLASTED against dBEST (BLASTn) and GenBanknr (BLASTx with RepeatMasker) to correlate contig identities, EST numbers from the tachyzoite and bradyzoite data sets, and putative homologies to each contig. A complete listing of the assembled bradyzoite contigs and matches to known proteins identified by BLASTx searches can be found at the Boothroyd laboratory home page (6a).
Nucleotide sequence accession numbers. Sequences for the in vivo bradyzoite EST project have been submitted to GenBank with accession no. AA519069 to AA520977 and AA531619 to AA532062.
| |
RESULTS |
|---|
|
|
|---|
Library generation. We constructed a cDNA library from mRNA isolated from the ME49 strain of parasites grown in vitro in human foreskin fibroblasts and subjected to high pH (~8.1) for 6 days (4, 29). Parasites subjected to such treatment are induced to express bradyzoite-specific genes such as BAG1 (3), SAG4 (also called P18) (30, 31), and BSR4 (also called P36) (16, 31). Switching was monitored by immunofluorescence with monoclonal antibody T8 4A12 (31) to detect expression of P36. The results showed that >95% of the parasites were successfully induced to express this marker (as against <5% in control cultures grown under normal tachyzoite conditions). This analysis does not reveal the extent of induction (i.e., how far along the parasites are on the pathway of tachyzoite-to-bradyzoite differentiation). In vitro bradyzoites are clearly immature, since they fail to express the tissue cyst antigen P21 at time points at least up to 72 h under "switch" conditions. In some strains this antigen can be detected at later time points (30), but its expression was not monitored in this study.
From the in vitro-bradyzoite cDNA library, 1,436 clones were subjected to sequence analysis, of which 761 yielded usable traces. To determine if this library would be informative, we compared the frequencies of known tachyzoite-stage-specific genes in this and the tachyzoite EST data set (1). We also examined the representations of three genes previously established to be induced during in vitro switching (29, 30, 33). The results indicated that there were still substantial representations of tachyzoite-specific genes: SAG1 and SAG2 transcripts were present at 0.9 and 0.4%, respectively, versus 1.9 and 0.8% in the ME49 tachyzoite EST data set. The drop of about twofold is consistent with the differentiating state of these parasites. It was disappointing, however, to find only a single EST (TgESTzz09e11:SAG4) for the known bradyzoite-specific genes. The abundance of SAG4 and LDH2 was expected to be low, and a frequency of 1 in 761 for a SAG4 transcript was not surprising. BAG1, however, is a relatively abundant transcript in mature bradyzoites which is strongly induced early in switching (29). While its frequency in a comparatively small number of ESTs cannot be predicted, the absence of this transcript and the background of tachyzoite sequences suggested that additional sequencing would not reveal a high proportion of ESTs in which we were interested, i.e., genes that would be upregulated in immature bradyzoites, which might then serve as markers for the differentiation process. An additional problem that we encountered during construction of the library was that there were clear differences in the susceptibilities of tachyzoites and encysted bradyzoites to techniques designed to solubilize them and isolate total RNA (21). As such, the resulting library may not have accurately represented the population of switching parasites. Despite this limitation, the data set from the in vitro library may still contain pointers to interesting genes. Indeed, our analysis of the in vivo data set (see below) revealed a number of singletons in the in vitro ESTs that are apparently restricted to the bradyzoite form and that may indeed represent transcripts from genes induced early after induction. Preliminary analysis, clustering, and BLASTx homology information for this library can be found in the Toxoplasma database of clustered ESTs (32). Because of these limitations, we focused our effort on ESTs from a library from mature bradyzoites isolated from the brains of infected mice (33). Based on an initial analysis of this library reported in the original publication and preliminary sequencing in the current study of a set of about 150 clones, it was clear that there was a strong bias in favor of truncated sequences clustered at the 3' ends of the respective genes. This bias is likely to have arisen from a number of technical problems encountered during the original construction of the library, which include (i) the difficulty of purifying cysts from infected animals and treating them to remove host cell contamination, (ii) the harsh treatment necessary to remove the bradyzoites from the cysts (acid-pepsin digestion), and (iii) preferential amplification of small fragments during PCR amplification of the cDNA prior to cloning. To overcome the small size and 3' bias, the library was amplified and inserts were excised by EcoRI and NotI digestion and size fractionated. Inserts in the 0.7- to 2.0-kb range were isolated from the gel and used to prepare a new directional library in pBluescript SK
. This size
range was chosen because it ensured that most ESTs would include coding
sequence. An initial sample of 20 clones from this library was
characterized for insert size and then sequenced. As expected, the
insert sizes ranged from 600 to 1,400 bp, with an average of ~850 bp.
By examining the five ESTs corresponding to known genes in this set, we
observed that all traces overlapped the coding region, confirming that
size selection had successfully eliminated the most extreme 5'-
truncated clones. This result was further confirmed upon analysis of
specific transcripts from the full-scale project (see below).
Furthermore, in this set of 20 ESTs, 2 ESTs corresponded to known
bradyzoite-specific genes (MAG1 and BAG1),
suggesting that a major investment in analysis of this library would be
fruitful. Based on this, a further 3,747 ESTs were sequenced from this
library, with 2,353 (62.8%) providing high-quality sequence data.
These data were assembled into 613 separate contigs, of which 235 are
singletons. Of the 613 separate contigs, 205 (33%) gave matches to
known proteins with a BLASTx high score of >70 (this is a measure of
the quality of the alignment; >70 indicates likely significance).
Table 1 shows a comparison of the
frequencies of ESTs of the most abundant tachyzoite- and
bradyzoite-specific genes identified previously (although note that
"specific" refers to expression of the protein product and that the
basis of this specificity is frequently not known). These data show
that most of the expected stage-specific genes are appropriately
represented in the ME49 tachyzoite and bradyzoite libraries (e.g., ESTs
for tachyzoite-specific genes are more abundant in the tachyzoite data
set than in the bradyzoite data set). Although we identified two ESTs
(TgESTzz27h08 and TgESTzz64g06) corresponding to SAG1 (whose
gene product [SAG1 or P30] is not normally detectable in bradyzoites
[12]), these two ESTs include sequences upstream of
the major transcription initiation site identified in tachyzoites.
Thus, they do not necessarily indicate that bradyzoites express low
levels of mature SAG1 transcripts. The origin and
significance of these transcripts, which presumably represent
initiation or readthrough from an upstream site, are unclear. The only
gene mapped to this region is SRS1 (13), whose polyadenylation site lies ~1.5 kb upstream of the 5'-most
SAG1 transcription start site. The two bradyzoite ESTs
extend only ~200 (TgESTzz27h08) and ~100 (TgESTzz64g06) bp upstream
of the SAG1 transcription start site.
|
33) for which 21 ESTs
were assembled into an apparently complete cDNA. The open reading frame
(ORF) it encodes has 50% identity to SAG4, is present at approximately
equivalent levels (21 versus 23 ESTs for SAG4), and is also bradyzoite
specific.
The fact that the libraries being compared here were constructed at
different times and in different laboratories (and one was the result
of amplification and subcloning) means that direct comparisons of
frequencies should be viewed with caution. Overall, however, the
changes in EST frequency for the known Toxoplasma genes
detailed in Table 1 reflect the known differences between the two
stages (15, 31). To further examine overlaps between the two
data sets and the reliability of putative stage-specific designations,
we performed BLASTn analyses for two genes, GRA2 and
BAG1, to map their relative start positions on the
full-length cDNA. These data are plotted in Fig.
1. ESTs for GRA2 were highly represented in both tachyzoite and bradyzoite libraries, and ESTs from
both data sets span almost the entire cDNA, with ~50% of sequences
in both data sets having 5' ends close to the putative transcription
start site (~1,050 bp; GenBank L01753 [27]). BAG1 expression is restricted to the bradyzoite data set,
and ESTs to this transcript also span the full-length cDNA, with
clustering at the presumed 5' end. For these genes at least, overlaps
between ESTs allow sampling of the entire transcript and direct
comparisons of frequencies. However, it should be noted that digestion
of cDNAs during construction or subcloning of the in vivo bradyzoite library will have shortened cDNAs that contain internal
EcoRI or NotI sites and thus may render
comparison of other cDNAs more difficult.
|
42) and
deoxyribose phosphate aldolase (TgESTzz32g04; P = 5.7 × 10
7) may be indicative of reliance on
specific pathways in DNA repair and nucleotide metabolism that offer
therapeutic potential. Likewise, a number of homologs of enzymes in the
metabolism of oxygen radicals are also present. These differences
require experimental confirmation but support the intuitive notion that
life within a cyst is different from that in a vacuole and more
stressful with respect to exposure to reactive metabolites.
|
81) prompted us to examine the regions of overlap of
this contig with the enolase-coding region and with contigs assembled
from the tachyzoite data set (Fig. 2).
While contigs from both forms overlap in the central portion of the ORF
with high homology to P. falciparum enolase (tachyzoite,
P = 1.4 × 10
27; bradyzoite,
P = 4.1 × 10
81), the two
Toxoplasma contigs are only 64% conserved at the nucleotide level and clearly represent different forms of the same enzymatic activity. The existence of bradyzoite-specific forms of lactate dehydrogenase (34) and enolase suggests that flux into or
through the lower arm of the glycolytic pathway is different between
the two stages. Previous studies have suggested that while both forms appear to maintain a high glycolytic flux, bradyzoites lack a functional tricaboxylic acid cycle (9). This would place
greater emphasis on conversion of pyruvate to lactate for
NAD+ regeneration in this stage. The two asexual life cycle
stages of Toxoplasma may also rely upon different energy
sources whose products enter the glycolytic pathway at different
points. These differences also reflect different anabolic requirements,
such as the need for bradyzoites to synthesize sugar-nucleotide
precursors (e.g., UDP-N-acetylglucosamine) as cyst wall
components (23). The metabolic consequences of these
differences are unclear but intriguing.
|
| |
DISCUSSION |
|---|
|
|
|---|
We have generated a total of 3,267 ESTs from in vivo and in vitro bradyzoites of T. gondii. The 2,350 ESTs derived from the in vivo cyst cDNA library fall into more than 600 clusters with homology to some 200 known genes, including several that appear specific to this stage. Prior to this study, only three genes expressed specifically in bradyzoites had been identified and cloned. The present study has therefore greatly extended our knowledge of genes expressed during this stage. In combination with the 7,400 ESTs from Toxoplasma tachyzoites, these new sequences provide valuable information for the further study of the biology of this important parasite.
The value of the EST approach in studying gene expression in T. gondii is borne out by the data in Tables 1 and 2. In a number of cases, we have been able to (i) assemble multiple ESTs into large contigs encompassing all or significant portions of the ORF of a gene and (ii) make crude estimates of the relative levels of expression of a transcript for a given gene based on EST frequencies. In a few cases, this information allows us to make deductions about the likely importance of this gene and/or its probable function, as a starting point for further investigation.
One limitation of the approach is exemplified by our attempts to generate information from the in vitro library of differentiating parasites. In this case, problems stem from (i) the fact that the in vitro bradyzoites are early in the process of switching and thus a high background of tachyzoite sequences persists and (ii) the fact that parasite preparations contain forms with different susceptibilities to chaotropic agents. Overall, these factors yielded a cDNA library with a high background of tachyzoite genes. Problems which stem from the background of tachyzoite-specific and constitutively expressed, highly abundant genes might be overcome in the future by using subtracted and normalized libraries or by alternative manual approaches such as differential display (18). These methods should be combined with optimized protocols for extracting mRNAs from encysting parasites. Nevertheless, the small number of sequences obtained from this library may still provide clues about genes involved in the switching process.
Currently, the Toxoplasma EST database is limited to genes expressed in the asexual stages of the parasite life cycle. The solution to this limitation would be to generate cDNA libraries from the sexual stages and sporozoites and/or to do genomic sequencing. With respect to the second of these, Toxoplasma has a haploid genome size of ~8 × 107 bp (8) and introns are moderately common. As such, the likely return on a small-scale genome sequencing effort would be relatively low compared to that seen here. It should be noted that useful information about the genes of Toxoplasma is also likely to be forthcoming from the Plasmodium falciparum genome project (20). Indeed, comparison of the two data sets is likely to be highly complementary and informative, especially where the fast evolutionary clock makes identification of Plasmodium genes difficult without the bridge provided by information from Toxoplasma.
In conclusion, the EST approach is an extremely cost-effective way to generate a very large amount of information on gene expression in a developmentally regulated system. Both developmental and constitutive classes of ESTs may reveal metabolic pathways critical to the parasite that serve as targets for therapeutic intervention. In the particular case being studied here, the project has produced a great many gene sequences from a stage of the parasite that is difficult to study and understanding of which is absolutely critical to control infection, especially in immunocompromised patients, where reactivation of chronic infection is a major cause of serious or even fatal disease.
| |
ACKNOWLEDGMENTS |
|---|
We thank our colleagues in our respective labs, Anthony Mossop for help with ICAASS and Doug Vollrath and David Roos (University of Pennsylvania) for helpful comments and for provision of key materials. The inception of this project is in part due to discussions held at a National Cooperative Drug Discovery Group meeting in 1995; the strong support and encouragement of Alex Fairfield, Keith Joiner, Barbara Laughon, and David Roos are gratefully acknowledged, as is the Washington University Genome Center EST Team.
This work was supported by grants from the NIH (AI30230 and AI41014). Construction of the in vivo cyst library was funded by the U.S. Department of Agriculture (grant 91-37204-6878). A.H. was supported by fellowships from the Swiss National Science Foundation and the Roche Research Foundation.
I. D. Manger and A. Hehl contributed equally to this work.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology and Immunology, Sherman Fairchild Science Building, 300 Pasteur Dr., Stanford, CA 94305-5124. Phone: (650) 723-7984. Fax: (650) 723-6853. E-mail: john.boothroyd{at}stanford.edu.
Editor: J. M. Mansfield
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Ajioka, J.,
J. C. Boothroyd,
B. P. Brunk,
A. Hehl,
L. Hillier,
I. D. Manger,
G. C. Overton,
M. Marra,
D. Roos,
K. L. Wan,
R. Waterston, and L. D. Sibley.
1998.
Sequencing of ESTs from the protozoan parasite Toxoplasma gondii: efficient identification of genes and identification of phylogenetically restricted sequences of the Apicomplexa.
Genome Res.
8:18-28 |
| 2. | Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1995. . Current protocols in molecular biology, vol. 1 to 3. John Wiley and Sons, Inc., New York, N.Y. |
| 3. | Bohne, W., U. Gross, D. J. Ferguson, and J. Heesemann. 1995. Cloning and characterization of a bradyzoite-specifically expressed gene. Mol. Microbiol. 16:1221-1230[Medline]. |
| 4. | Bohne, W., S. F. Parmley, S. Yang, and U. Gross. 1996. Bradyzoite-specific genes. Curr. Top. Microbiol. Immunol. 219:81-91[Medline]. |
| 5. | Bohne, W., A. Wirsing, and U. Gross. 1997. Bradyzoite-specific gene expression in Toxoplasma gondii requires minimal genomic elements. Mol. Biochem. Parasitol. 85:89-98[Medline]. |
| 6. | Boothroyd, J. C., A. B. Hehl, L. J. Knoll, and I. D. Manger. 1998. The surface of Toxoplasma: more and less. Int. J. Parasitol. 28:3-9[Medline]. |
| 6a. | Boothroyd laboratory home page. http://cmgm.stanford.edu/micro/boothroyd/toxo1.html. |
| 7. | Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium. Anal. Biochem. 162:156-159[Medline]. |
| 8. | Cornelissen, A. W., J. P. Overdulve, and M. van der Ploeg. 1984. Determination of nuclear DNA of five eucoccidian parasites, Isospora (Toxoplasma) gondii, Sarcocystis cruzi, Eimeria tenella, E. acervulina and Plasmodium berghei, with special reference to gamontogenesis and meiosis in I. (T.) gondii. Parasitology 88:531-553. |
| 9. | Denton, H., S. M. Brown, C. W. Roberts, J. Alexander, V. McDonald, K. W. Thong, and G. H. Coombs. 1996. Comparison of the phosphofructokinase and pyruvate kinase activities of Cryptosporidium parvum, Eimeria tenella and Toxoplasma gondii. Mol. Biochem. Parasitol. 76:23-29[Medline]. |
| 10. | Denton, H., C. W. Roberts, J. Alexander, K. W. Thong, and G. H. Coombs. 1996. Enzymes of energy metabolism in the bradyzoites and tachyzoites of Toxoplasma gondii. FEMS Microbiol. Lett. 137:103-108[Medline]. |
| 11. | Dubey, J. P. 1993. Toxoplasma, Neospora, Sarcosystis, and other tissue cyst-forming coccidia of humans and animals, p. 1-158. In J. P. Kreier (ed.), Parasitic protozoa, vol. 6. Academic Press, New York, N.Y. |
| 12. | Gross, U., W. Bohne, C. G. Luder, R. Lugert, F. Seeber, C. Dittrich, F. Pohl, and D. J. Ferguson. 1996. Regulation of developmental differentiation in the protozoan parasite Toxoplasma gondii. J. Eukaryot. Microbiol. 43:114S-116S[Medline]. |
| 13. | Hehl, A. B., T. Krieger, and J. C. Boothroyd. 1997. Identification and characterization of SRS1, a Toxoplasma gondii surface antigen upstream of and related to SAG1. Mol. Biochem. Parasitol. 89:271-282[Medline]. |
| 14. | Huskinson-Mark, J., F. G. Araujo, and J. S. Remington. 1991. Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii. J. Infect. Dis. 164:170-171[Medline]. |
| 15. |
Kasper, L. H.
1989.
Identification of stage-specific antigens of Toxoplasma gondii.
Infect. Immun.
57:668-672 |
| 16. |
Knoll, L. J., and J. C. Boothroyd.
1998.
Isolation of developmentally regulated genes from Toxoplasma gondii by a gene trap with the positive and negative selectable marker hypoxanthine-xanthine-guanine phosphoribosyltransferase.
Mol. Cell. Biol.
18:807-814 |
| 17. |
Lee, N. H.,
K. G. Weinstock,
E. F. Kirkness,
J. A. Earle-Hughes,
R. A. Fuldner,
S. Marmaros,
A. Glodek,
J. D. Gocayne,
M. D. Adams,
A. R. Kerlavage,
C. M. Fraser, and J. C. Venter.
1995.
Comparative expressed-sequence-tag analysis of differential gene expression profiles in pc-12 cells before and after nerve growth factor treatment.
Proc. Natl. Acad. Sci. USA
92:8303-8307 |
| 18. | Liang, P., L. Averboukh, and A. B. Pardee. 1994. Methods of differential display, p. 3-16. In K. W. Adolph (ed.), Methods in molecular genetics, vol. 5. Gene and chromosome analysis, part C. Academic Press, Inc., San Diego, Calif. |
| 19. | Luft, B. J., and J. S. Remington. 1992. Toxoplasmic encephalitis in AIDS. Clin. Infect. Dis. 15:211-222[Medline]. |
| 20. | Malarial Genome Project home page. http://www.sanger.ac.uk/Projects/P_falciparum/. |
| 20a. | Manger, I. D., A. B. Hehl, and J. C. Boothroyd. The surface of Toxoplasma tachyzoites is dominated by a family of GPI-anchored antigens related to SAG1. Submitted for publication. |
| 21. | Manger, I. D., A. B. Hehl, and J. C. Boothroyd. Unpublished data. |
| 22. | Odberg-Ferragut, C., M. Soete, A. Engels, B. Samyn, A. Loyens, J. Van Beeumen, D. Camus, and J. F. Dubremetz. 1996. Molecular cloning of the Toxoplasma gondii sag4 gene encoding an 18 kDa bradyzoite specific surface protein. Mol. Biochem. Parasitol. 82:237-244[Medline]. |
| 23. | Ortega, E., and J. C. Boothroyd. Unpublished data. |
| 24. | Parmley, S. F. Unpublished results. |
| 25. | Parmley, S. F., L. M. Weiss, and S. Yang. 1995. Cloning of a bradyzoite-specific gene of Toxoplasma gondii encoding a cytoplasmic antigen. Mol. Biochem. Parasitol. 73:253-257[Medline]. |
| 26. | Parmley, S. F., S. Yang, G. Harth, L. D. Sibley, A. Sucharczuk, and J. S. Remington. 1994. Molecular characterization of a 65-kilodalton Toxoplasma gondii antigen. Mol. Biochem. Parasitol. 66:283-296[Medline]. |
| 27. | Prince, J. B., F. G. Araujo, J. S. Remington, J. L. Burg, J. C. Boothroyd, and S. D. Sharma. 1989. Cloning of cDNAs encoding a 28 kilodalton antigen of Toxoplasma gondii. Mol. Biochem. Parasitol. 34:3-13[Medline]. |
| 28. | Sibley, L. D., and D. K. Howe. 1996. Genetic basis of pathogenicity in toxoplasmosis. Curr. Top. Microbiol. Immunol. 219:3-15[Medline]. |
| 29. | Soete, M., D. Camus, and J. F. Dubremetz. 1994. Experimental induction of bradyzoite-specific antigen expression and cyst formation by the RH strain of Toxoplasma gondii in vitro. Exp. Parasitol. 78:361-370[Medline]. |
| 30. | Soete, M., B. Fortier, D. Camus, and J. F. Dubremetz. 1993. Toxoplasma gondii: kinetics of bradyzoite-tachyzoite interconversion in vitro. Exp. Parasitol. 76:259-264[Medline]. |
| 31. |
Tomavo, S.,
B. Fortier,
M. Soete,
C. Ansel,
D. Camus, and J. F. Dubremetz.
1991.
Characterization of bradyzoite-specific antigens of Toxoplasma gondii.
Infect. Immun.
59:3750-3753 |
| 32. | Toxoplasma Database of Clustered Expressed Sequence Tags. http://daphne.humgen.upenn.edu:1024/toxodb/ver_1/toxodb.html. |
| 33. | Yang, S., and S. F. Parmley. 1995. A bradyzoite stage-specifically expressed gene of Toxoplasma gondii. Mol. Biochem. Parasitol. 73:291-294[Medline]. |
| 34. | Yang, S., and S. F. Parmley. 1997. Toxoplasma gondii expresses two distinct lactate dehydrogenase homologous genes during its life cycle in intermediate hosts. Gene 184:1-12[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»